Dr. Fux is a bioanalytical chemist with more than 15 years expertise in mass spectrometry and separation science. He graduated from the University of Nottingham Trent in UK with a BSC(Hons) in Chemistry and received a MSc degree in Chemistry from Basel University in Switzerland.  He then completed a Ph.D. in analytical Chemistry from the Dublin Institute of Technology- Ireland in the field of biotoxins before a post-doctoral training in the US FDA focusing on the detection of neurotoxins with mass spectrometry. In 2011, he then joined metanomics, a BASF group company based in Berlin, which has pioneered the discipline of metabolic functional genomics and industrial metabolomics. Dr Fux held several R&D leadership roles at metanomics where he supervised high throughput analysis and method development activities of targeted and untargeted metabolomics. In 2017, Dr Fux joined the R&D of Roche Diagnostics in Munich - Germany to focus on the development of in-vitro diagnostics assays. He is now responsible for mass spectrometry applications, including metabolite profiling. Since 2021, Dr Fux has taken the leadership of a new IFCC working group focusing on metabolomics applications within the emerging technology division.